Journal of Investigational Allergology and Clinical Immunology This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Very Rapid Improvement in Extended Nitric Oxide Parameters Is Associated With Clinical and Functional Improvement in Patients With Chronic Rhinosinusitis With Nasal Polyps Treated With Dupilumab
CONCLUSION: Dupilumab is associated with very rapid improvement in type 2 inflammation in all airway areas. This is associated with improved lung function and clinical parameters in patients with CRSwNP.PMID:38095494 | DOI:10.18176/jiaci.0851 (Source: Journal of Investigational Allergology and Clinical Immunology)
Source: Journal of Investigational Allergology and Clinical Immunology - December 14, 2023 Category: Allergy & Immunology Authors: G Paoletti M Casini L Malvezzi F Pirola E Russo E Nappi G Q Muci C Montagna M R Messina S Ferri F Racca D Lamacchia G Cataldo F Puggioni A De Virgilio F Ferreli G Mercante G Spriano G W Canonica E Heffler Source Type: research

Anaphylaxis Management in the GALAXIA 2022 Update
J Investig Allergol Clin Immunol. 2023 Dec;33(6):486-487. doi: 10.18176/jiaci.0962.NO ABSTRACTPMID:38095495 | DOI:10.18176/jiaci.0962 (Source: Journal of Investigational Allergology and Clinical Immunology)
Source: Journal of Investigational Allergology and Clinical Immunology - December 14, 2023 Category: Allergy & Immunology Authors: A Prieto-Moreno Y Puente-Crespo V Cardona B de la Hoz M C Dieguez D Gonz ález-de-Olano A Habernau C Perales-Chorda R Mu ñoz-Cano Source Type: research

Olfactory Function and Biologic Treatments: Comment on Available Real-Life Studies
J Investig Allergol Clin Immunol. 2023 Dec;33(6):502-503. doi: 10.18176/jiaci.0929.NO ABSTRACTPMID:38095496 | DOI:10.18176/jiaci.0929 (Source: Journal of Investigational Allergology and Clinical Immunology)
Source: Journal of Investigational Allergology and Clinical Immunology - December 14, 2023 Category: Allergy & Immunology Authors: B N Landis Y Coattrenec M B Soyka Source Type: research

Reply to "Olfactory Function and Biologic Treatments: A Comment on Available Real-life Studies"
J Investig Allergol Clin Immunol. 2023 Dec;33(6):503-504. doi: 10.18176/jiaci.0953.NO ABSTRACTPMID:38095497 | DOI:10.18176/jiaci.0953 (Source: Journal of Investigational Allergology and Clinical Immunology)
Source: Journal of Investigational Allergology and Clinical Immunology - December 14, 2023 Category: Allergy & Immunology Authors: B Barroso M Valverde-Monge I Alobid J M Olaguibel M J Rial S Quirce E Arismendi P Barranco D Betancor I Bobolea B C árdaba M J Cruz Carmona E Curto J Dom ínguez-Ortega F J Gonz ález-Barcala C Mart ínez-Rivera I Mah íllo-Fernández X Mu ñoz C Picado Source Type: research

Kounis Syndrome Induced by Lidocaine
J Investig Allergol Clin Immunol. 2023 Dec;33(6):505-506. doi: 10.18176/jiaci.0936.NO ABSTRACTPMID:38095498 | DOI:10.18176/jiaci.0936 (Source: Journal of Investigational Allergology and Clinical Immunology)
Source: Journal of Investigational Allergology and Clinical Immunology - December 14, 2023 Category: Allergy & Immunology Authors: Ü Dikici Ö Özdemir Source Type: research

Kounis Syndrome After Lidocaine Injection
J Investig Allergol Clin Immunol. 2023 Dec;33(6):506-507. doi: 10.18176/jiaci.0950.NO ABSTRACTPMID:38095499 | DOI:10.18176/jiaci.0950 (Source: Journal of Investigational Allergology and Clinical Immunology)
Source: Journal of Investigational Allergology and Clinical Immunology - December 14, 2023 Category: Allergy & Immunology Authors: I Garcia-Nunez M A Algaba-Marmol J M Ignacio-Garcia Source Type: research

Immunoglobulin E Deficiency and Autoimmune Disease
J Investig Allergol Clin Immunol. 2023 Dec;33(6):508-509. doi: 10.18176/jiaci.0942.NO ABSTRACTPMID:38095500 | DOI:10.18176/jiaci.0942 (Source: Journal of Investigational Allergology and Clinical Immunology)
Source: Journal of Investigational Allergology and Clinical Immunology - December 14, 2023 Category: Allergy & Immunology Authors: Ö Özdemir Source Type: research

In Reply to "Immunoglobulin E Deficiency and Autoimmune Disease"
J Investig Allergol Clin Immunol. 2023 Dec;33(6):509-510. doi: 10.18176/jiaci.0952.NO ABSTRACTPMID:38095501 | DOI:10.18176/jiaci.0952 (Source: Journal of Investigational Allergology and Clinical Immunology)
Source: Journal of Investigational Allergology and Clinical Immunology - December 14, 2023 Category: Allergy & Immunology Authors: C Vidal authors Source Type: research

Fundamental Aspects and Relevance of Components in Antihistamine Eye Drops
J Investig Allergol Clin Immunol. 2023 Dec;33(6):431-438. doi: 10.18176/jiaci.0963.ABSTRACTOcular allergy covers a series of immune-allergic inflammatory diseases of the ocular surface, with different degrees of involvement and severity. These pathologies are caused by a variety of IgE- and non-IgE-mediated immune mechanisms and may involve all parts of the external eye, including the conjunctiva, cornea, eyelids, tear film, and commensal flora. The most frequent is allergic conjunctivitis, a condition with different clinical forms that are classified according to the degree of involvement and the presence or absence of pr...
Source: Journal of Investigational Allergology and Clinical Immunology - December 14, 2023 Category: Allergy & Immunology Authors: R Herrero-Vanrell I J áuregui Presa A Leceta Bilbao J Montero-Iruzubieta Source Type: research

The Importance of Preventing and Managing Tear Dysfunction Syndrome in Allergic Conjunctivitis and How to Tackle This Problem
J Investig Allergol Clin Immunol. 2023 Dec;33(6):439-445. doi: 10.18176/jiaci.0960.ABSTRACTTear dysfunction syndrome, also known as dry eye disease (DED), is a multifactorial disease of the ocular surface characterized by the loss of tear film homeostasis. DED shows a significant clinical overlap with ocular allergy (OA), which alters tear film homeostasis, thus predisposing the patient to DED. Both conditions constitute the most common ocular surface disorders and have a potentially severe impact on patients' quality of life. Clinical practice guidelines recommend topical therapies as first-line treatment for OA. However,...
Source: Journal of Investigational Allergology and Clinical Immunology - December 14, 2023 Category: Allergy & Immunology Authors: J Montero-Iruzubieta M C Sanchez Hernandez I D ávila A Leceta Source Type: research